Pulmonary Adult Med

Front 1

8th leading cause of death

(US)

Back 1

pneumonia

Front 2

most deadly infectious disease

(US)

Back 2

pneumonia

Front 3

MC cause bacterial pneumonia

Back 3

Strep. pneumoniae

Front 4

MC cause pneumonia <35 y/o

Back 4

Mycoplasma

Front 5

MC cause atypical pneumonia

Back 5

Mycoplasma #1

Chlamydia #2

Front 6

MC cause pneumonia (water/summer)

Back 6

Legionella

Front 7

MC cause pneumonia in COPD & Alcoholics

Back 7

H. influenza

Front 8

MC cause pneumonia in DM & Alcoholics

Back 8

Klebsiella pneumoniae

Front 9

MC cause viral pneumonia

Back 9

RSV

Front 10

MC cause pneumonia in pediatric

Back 10

RSV

Front 11

MC cause pneumonia in IV drug users

Back 11

S. aureus

Front 12

MC cause pneumonia in HIV/Immunocompromised

Back 12

Pneumocystis (fungus)

Front 13

Common viral causes of CAP

Back 13

Influenza,

RSV,

Adenovirus,

Parainfluenza

Front 14

CAP abx (strong recommendation)- Outpatient

Back 14

macrolide (PO)

Front 15

CAP abx (weak recommendation)- Outpatient

Back 15

doxycycline (PO)

Front 16

MRSA CAP abx- Outpatient

Back 16

linezolid (PO)

vancomycin (IV)

Front 17

CAP w/ comorbidity abx- Outpatient

Back 17

fluoroquinolone (PO)

macrolide + beta-lactam (PO)

Front 18

CAP abx- Inpatient (non-ICU)

Back 18

fluoroquinolone (RESPIR)

AND

beta-lactam + macrolide (IV)

Front 19

CAP- Always treat/expect:

Back 19

Strep. pneumoniae,

H. influenza,

M. catarrhalis,

K. pneumoniae

Front 20

Direct admission to ICU required for:

Back 20

septic shock requiring vasopressors;

OR

acute resp failure req. intub & mechanical vent.;

OR

3 of minor criteria for severe CAP (recommend)

Front 21

MC etiologies of CAP- Outpatient

Back 21

Strep. pneumoniae,

Mycoplasma pneumoniae,

H. influenza,

Chlamydophila pneumoniae,

respiratory viruses

Front 22

MC etiologies of CAP- Inpatient (non-ICU)

Back 22

Strep. pneumoniae,

Mycoplasma pneumoniae,

Chlamydophila pneumoniae,

H. influenza,

Legionella species,

aspiration,

respiratory viruses

Front 23

Considerations for CAP abx (Outpatient)

Back 23

start within 6 hours of PRESENTATION

AND

Previously HEALTHY

AND

no use of antimicrobials w/in previous 6 months

Front 24

CAP abx- Inpatient (ICU)

Back 24

azithromycin (PO)

OR

fluoroquinolone + antipneumoc. b-lactam (PO)

Front 25

Suspect Pseudomonas CAP abx- Inpatient (ICU)

Back 25

antipneumoc/antipsuedomon b-lactam + ciprofloxacin or levofloxacin (PO)

OR

above b-lactam + amizoglycoside + azithromycin (PO)

OR

above b-lactam +aminoglycoside + antipneumococcal fluoroquinolone (PO)

Front 26

Add abx if suspected MRSA pneumonia:

Back 26

vancomycin

OR

linozelid

(PO-if CAP; IV-if nosocomial)

Front 27

Hospital Acquired Pneumonia

(HAP)

Back 27

48 hours of admission

OR

healthcare facility

Front 28

Nosocomial Pneumonia

Back 28

Hospital Acquired (HAP)

OR

Health Care Associated (HCAP)

OR

extensive contact w/ healthcare

OR

Ventilator Associated (VAP)

Front 29

Ventilator Associated Pneumonia (VAP)

Back 29

fever, leukocystosis, purulent sputum

AND

new or progressive CXR opacity

Front 30

Common etiologies of nosocomial pneumonia

Back 30

Strep. pneumoniae (often MDR),

MSSA, MRSA,

MDRGNR (ESBL-producing)

-Klebsiella,

-E. coli,

-Enterobacter,

-Pseudomonas aeruginosa,

-Acinetobacter spp

Front 31

Nosocomial pneumonia abx- LOW risk for MDR

Back 31

ceftriaxone (IV)

OR

fluoroquinolone (IV)

OR

ampicillin-sulbactam (IV)

OR

pipercillin-taxobactam (IV)

OR

ertapenem (IV)

Front 32

Nosocomial pneumonia abx- HIGH risk for MDR

Back 32

1st antipseudomonal (IV): cephalosporin or b-lactam or pipercillin-tazobactam

AND

2nd antipseudomonal (IV): fluoroquinolone or macrolide

Front 33

rust-colored

Back 33

Strep. pneumoniae or Pneumococcal sputum

Front 34

currant-colored

Back 34

Klebsiella sputum

Front 35

mucoid or sticky

Back 35

Mycoplasma sputum

Front 36

could be yellow-green color

Back 36

Strep. pneumoniae or Pneumococcal sputum